Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats.
about
The pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulationsCombination therapy as a tool to prevent emergence of bacterial resistance.Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsisCharacterizing "Adversity" of Pathology Findings in Nonclinical Toxicity Studies: Results from the 4th ESTP International Expert Workshop.Principles for Assessing Adversity in Toxicologic Clinical Pathology.Aminoglycosides: current role in antimicrobial therapy.Role of pharmacokinetics in the outcome of infections.A randomised comparison of ceftazidime and piperacillin, both in combination with flucloxacillin for treatment of febrile episodes in neutropenic children. Finnish Three-Centre Study.Postantibiotic effect of ceftriaxone and gentamicin alone and in combination on Klebsiella pneumoniae, Pseudomonas aeruginosa and Streptococcus viridans.Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes.Optimization and evaluation of piperacillin plus tobramycin combination dosage regimens against Pseudomonas aeruginosa for patients with altered pharmacokinetics via the hollow-fiber infection model and mechanism-based modeling.
P2860
Q28485988-2661E78C-30C4-4378-B515-D8ABD855D889Q33961767-78871EDB-6F64-42B3-9B7A-86C815110769Q35131156-66145705-714B-47F9-9F77-B7A34ACAB79CQ35810298-1F224486-52E0-4C6A-9EC1-94B7BE2FB277Q38814376-A0E0302B-E3F0-4D7A-8B40-C05C44B10918Q39037976-DEE24F20-20E6-4422-AEC4-56D0A665D26AQ39608639-3FAEAF0A-2AA2-458E-AC59-D736BA2208D7Q39639407-C5F62187-3503-4653-B798-B1273CE40BA5Q40767303-657775C9-7714-446C-9FC3-AC1374221F2FQ44024994-98B23F9C-E6C5-4E3E-8654-ED49E3436BCCQ47656109-B93E01C7-C67F-4C59-BBBD-1C92FF7F395BQ49792113-AB364DB1-6C62-4F61-B287-22D74E6E9518
P2860
Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Comparative activities of pipe ...... nfections in neutropenic rats.
@ast
Comparative activities of pipe ...... nfections in neutropenic rats.
@en
type
label
Comparative activities of pipe ...... nfections in neutropenic rats.
@ast
Comparative activities of pipe ...... nfections in neutropenic rats.
@en
prefLabel
Comparative activities of pipe ...... nfections in neutropenic rats.
@ast
Comparative activities of pipe ...... nfections in neutropenic rats.
@en
P2093
P2860
P356
P1476
Comparative activities of pipe ...... nfections in neutropenic rats.
@en
P2093
P2860
P304
P356
10.1128/AAC.28.6.735
P407
P577
1985-12-01T00:00:00Z